Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer

Clinical trial NCT05494580 · COMPLETED

Trial details

NCT number: NCT05494580
Sponsor: Sun Yat-sen University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Ovarian Carcinoma Platinum-resistant Ovarian Cancer Fallopian Tube Carcinosarcoma Primary Peritoneal Cancer

Start date: 2022-09-22
Primary completion: 2024-06-20
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.